Kody Technolab Reports Nil Deviation in Utilization of Preferential Warrant Proceeds
Kody Technolab Ltd · Others (Uncategorized) · 03 Nov 2026, 12:41 am
Kody Technolab Reports Nil Deviation in Utilization of Preferential Warrant Proceeds Kody Technolab reported nil deviation or variation in the utilization of funds raised via preferential convertible warrants for the period ended 30th Sep'26. The company received ₹900.17 Lakhs on 7th Aug'26 as the 75% balance exercise price for converting 1,23,100 warrants at ₹975 per share, utilizing ₹692.59 Lakhs for working capital and ₹207.58 Lakhs for subsidiary/JV investments. Additionally, across its ₹6,558.00 Lakhs warrant proceeds, funds have been deployed toward working capital, investment in World EMS Private Limited, and general corporate purposes with zero deviation.
Original exchange filing (PDF)
More announcements from Kody Technolab Ltd
- Kody Technolab Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "Kody Technolab Enters the United States with First Commercial Order for Odigo AI Robots". · 12 Nov 2026
- Kody Technolab Limited has informed the Exchange regarding allotment of 102500 securities pursuant to Preferential Issue at its meeting held on November 06, 2026 · 06 Nov 2026
- Kody Technolab Limited has informed the Exchange regarding Outcome of Board Meeting held on November 06, 2026. · 06 Nov 2026
- Kody Technolab Limited has informed the Exchange regarding Outcome of Board Meeting held on November 06, 2026. · 06 Nov 2026
- Kody Technolab Limited has informed the Exchange about Shareholders letter dated November 02, 2026. · 03 Nov 2026
- Kody Technolab Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 02 Nov 2026
- Kody Technolab Limited has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 02 Nov 2026
